{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T17:03:07Z","timestamp":1787850187640,"version":"build-2784847793"},"reference-count":121,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","interventional.theclinics.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Interventional Cardiology Clinics"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.iccl.2023.06.006","type":"journal-article","created":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T21:32:37Z","timestamp":1691011957000},"page":"453-467","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Significance of Kidney Disease in Cardiovascular Disease Patients"],"prefix":"10.1016","volume":"12","author":[{"given":"Adhya","family":"Mehta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rishi","family":"Chandiramani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Spirito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit","family":"Vogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxana","family":"Mehran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.iccl.2023.06.006_bib1","first-page":"338","article-title":"Cases and observations illustrative of renal disease accompanied with the secretion of albuminous urine","volume":"10","author":"Bright","year":"1836","journal-title":"Guy's Hospital Report"},{"issue":"16","key":"10.1016\/j.iccl.2023.06.006_bib2","doi-asserted-by":"crossref","first-page":"e840","DOI":"10.1161\/CIR.0000000000000664","article-title":"Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies: A Scientific Statement From the American Heart Association","volume":"139","author":"Rangaswami","year":"2019","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.iccl.2023.06.006_bib3","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1093\/ndt\/gfq136","article-title":"Definition and classification of Cardio-Renal Syndromes: workgroup statements from the 7th ADQI Consensus Conference","volume":"25","author":"House","year":"2010","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"10.1016\/j.iccl.2023.06.006_bib4","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s10741-005-6129-4","article-title":"The cardiorenal syndrome: lessons from the ADHERE database and treatment options","volume":"9","author":"Heywood","year":"2004","journal-title":"Heart Fail Rev"},{"issue":"10225","key":"10.1016\/j.iccl.2023.06.006_bib5","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","article-title":"Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"395","year":"2020","journal-title":"Lancet"},{"issue":"10159","key":"10.1016\/j.iccl.2023.06.006_bib6","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0140-6736(18)32279-7","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"392","year":"2018","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.iccl.2023.06.006_bib7","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/sj.ki.5002273","article-title":"Chronic kidney disease management in the United Kingdom: NEOERICA project results","volume":"72","author":"Stevens","year":"2007","journal-title":"Kidney Int"},{"issue":"8","key":"10.1016\/j.iccl.2023.06.006_bib8","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.jacc.2004.06.072","article-title":"The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease","volume":"44","author":"Ezekowitz","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.iccl.2023.06.006_bib9","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/eurheartj\/eht386","article-title":"Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis","volume":"35","author":"Damman","year":"2014","journal-title":"Eur Heart J"},{"issue":"7","key":"10.1016\/j.iccl.2023.06.006_bib10","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1681\/ASN.2005101085","article-title":"Chronic kidney disease and mortality risk: a systematic review","volume":"17","author":"Tonelli","year":"2006","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"10","key":"10.1016\/j.iccl.2023.06.006_bib11","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1681\/ASN.2014070714","article-title":"Cause of Death in Patients with Reduced Kidney Function","volume":"26","author":"Thompson","year":"2015","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"10075","key":"10.1016\/j.iccl.2023.06.006_bib12","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/S0140-6736(16)32064-5","article-title":"Chronic Kidney Disease","volume":"389","author":"Webster","year":"2017","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.iccl.2023.06.006_bib13","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/eurheartj\/ehp507","article-title":"Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative","volume":"31","author":"Ronco","year":"2010","journal-title":"Eur Heart J"},{"issue":"10","key":"10.1016\/j.iccl.2023.06.006_bib14","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.2215\/CJN.04020417","article-title":"Epidemiology and Natural History of the Cardiorenal Syndromes in a Cohort with Echocardiography","volume":"12","author":"Mavrakanas","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.iccl.2023.06.006_bib15","doi-asserted-by":"crossref","first-page":"e0192895","DOI":"10.1371\/journal.pone.0192895","article-title":"Cardiovascular disease risk factors in chronic kidney disease: A systematic review and meta-analysis","volume":"13","author":"Major","year":"2018","journal-title":"PLoS One"},{"issue":"18","key":"10.1016\/j.iccl.2023.06.006_bib16","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1161\/01.CIR.97.18.1837","article-title":"Prediction of coronary heart disease using risk factor categories","volume":"97","author":"Wilson","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.iccl.2023.06.006_bib17","series-title":"Chronic kidney disease in the United States, 2021","year":"2021"},{"issue":"3","key":"10.1016\/j.iccl.2023.06.006_bib18","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/MNH.0000000000000492","article-title":"Blood pressure targets and kidney and cardiovascular disease: same data but discordant guidelines","volume":"28","author":"Roehm","year":"2019","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"1","key":"10.1016\/j.iccl.2023.06.006_bib19","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.semnephrol.2018.10.003","article-title":"Cardiorenal Syndrome in Acute Kidney Injury","volume":"39","author":"Di Lullo","year":"2019","journal-title":"Semin Nephrol"},{"issue":"4","key":"10.1016\/j.iccl.2023.06.006_bib20","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1161\/01.HYP.0000120964.22281.3e","article-title":"How does angiotensin II cause renal injury?","volume":"43","author":"Long","year":"2004","journal-title":"Hypertension"},{"issue":"8","key":"10.1016\/j.iccl.2023.06.006_bib21","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.hlc.2016.02.022","article-title":"Role of Renal Oxidative Stress in the Pathogenesis of the Cardiorenal Syndrome","volume":"25","author":"Giam","year":"2016","journal-title":"Heart Lung Circ"},{"issue":"2","key":"10.1016\/j.iccl.2023.06.006_bib22","doi-asserted-by":"crossref","first-page":"76","DOI":"10.14740\/cr955","article-title":"An Update on the Pathophysiology and Treatment of Cardiorenal Syndrome","volume":"11","author":"Raina","year":"2020","journal-title":"Cardiol Res"},{"issue":"6","key":"10.1016\/j.iccl.2023.06.006_bib23","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1253\/circj.CJ-14-0470","article-title":"Insights Into the Activation and Inhibition of Angiotensin II Type 1 Receptor in the Mechanically Loaded Heart","volume":"78","author":"Wu","year":"2014","journal-title":"Circ J"},{"issue":"3","key":"10.1016\/j.iccl.2023.06.006_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/S0002-9149(97)00465-7","article-title":"Effects of Angiotensin-Converting Enzyme Inhibition and Angiotensin II AT1 Receptor Antagonism on Cardiac Parameters in Left Ventricular Hypertrophy","volume":"80","author":"Zhu","year":"1997","journal-title":"Am J Cardiol"},{"issue":"6","key":"10.1016\/j.iccl.2023.06.006_bib25","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s00395-009-0043-1","article-title":"Angiotensin type 1 receptor mediates thyroid hormone-induced cardiomyocyte hypertrophy through the Akt\/GSK-3\u03b2\/mTOR signaling pathway","volume":"104","author":"Diniz","year":"2009","journal-title":"Basic Res Cardiol"},{"issue":"3","key":"10.1016\/j.iccl.2023.06.006_bib26","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/fcp.12031","article-title":"AT1 blockade abolishes left ventricular hypertrophy in heterozygous cMyBP-C null mice: role of FHL1","volume":"28","author":"Vignier","year":"2014","journal-title":"Fund Clin Pharmacol"},{"issue":"24","key":"10.1016\/j.iccl.2023.06.006_bib27","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","article-title":"Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes","volume":"358","author":"Patel","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"20","key":"10.1016\/j.iccl.2023.06.006_bib28","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1093\/eurheartj\/ehx118","article-title":"Symmetric dimethylarginine, high-density lipoproteins and cardiovascular disease","volume":"38","author":"Zewinger","year":"2017","journal-title":"Eur Heart J"},{"issue":"11","key":"10.1016\/j.iccl.2023.06.006_bib29","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1681\/ASN.2013111212","article-title":"HDL in children with CKD promotes endothelial dysfunction and an abnormal vascular phenotype","volume":"25","author":"Shroff","year":"2014","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.iccl.2023.06.006_bib30","doi-asserted-by":"crossref","first-page":"e0170781","DOI":"10.1371\/journal.pone.0170781","article-title":"Mononuclear Phagocytes Are Dispensable for Cardiac Remodeling in Established Pressure-Overload Heart Failure","volume":"12","author":"Patel","year":"2017","journal-title":"PLoS One"},{"issue":"13","key":"10.1016\/j.iccl.2023.06.006_bib31","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1111\/bph.15065","article-title":"Cardiorenal syndrome: Multi-organ dysfunction involving the heart, kidney and vasculature","volume":"177","author":"Savira","year":"2020","journal-title":"Br J Pharmacol"},{"issue":"21","key":"10.1016\/j.iccl.2023.06.006_bib32","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1016\/j.jacc.2018.03.490","article-title":"Inhibition of Interleukin-1\u03b2 by Canakinumab and Cardiovascular Outcomes in Patients With Chronic Kidney Disease","volume":"71","author":"Ridker","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.iccl.2023.06.006_bib33","doi-asserted-by":"crossref","first-page":"e12305","DOI":"10.1111\/micc.12305","article-title":"Immune cells in repair of the infarcted myocardium","volume":"24","author":"Chen","year":"2017","journal-title":"Microcirculation"},{"key":"10.1016\/j.iccl.2023.06.006_bib34","first-page":"148082","volume":"2015","author":"Clementi","year":"2015"},{"issue":"4","key":"10.1016\/j.iccl.2023.06.006_bib35","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1159\/000327131","article-title":"Does Uremia Cause Vascular Dysfunction","volume":"34","author":"Brunet","year":"2011","journal-title":"Kidney Blood Press Res"},{"issue":"3","key":"10.1016\/j.iccl.2023.06.006_bib36","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1159\/000355405","article-title":"Uric Acid - Key Ingredient in the Recipe for Cardiorenal Metabolic Syndrome","volume":"3","author":"Chaudhary","year":"2013","journal-title":"Cardiorenal Med"},{"issue":"9","key":"10.1016\/j.iccl.2023.06.006_bib37","doi-asserted-by":"crossref","first-page":"352","DOI":"10.3390\/toxins10090352","article-title":"Cardiotoxicity of Uremic Toxins: A Driver of Cardiorenal Syndrome","volume":"10","author":"Lekawanvijit","year":"2018","journal-title":"Toxins"},{"issue":"3","key":"10.1016\/j.iccl.2023.06.006_bib38","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1093\/ndt\/gfq580","article-title":"p-Cresyl sulphate and indoxyl sulphate predict progression of chronic kidney disease","volume":"26","author":"Wu","year":"2011","journal-title":"Nephrol Dial Transplant"},{"issue":"8","key":"10.1016\/j.iccl.2023.06.006_bib39","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1093\/eurjhf\/hfq106","article-title":"Relations of serum phosphorus levels to echocardiographic left ventricular mass and incidence of heart failure in the community","volume":"12","author":"Dhingra","year":"2010","journal-title":"Eur J Heart Fail"},{"issue":"17","key":"10.1016\/j.iccl.2023.06.006_bib40","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1161\/CIRCULATIONAHA.105.553198","article-title":"Relation Between Serum Phosphate Level and Cardiovascular Event Rate in People With Coronary Disease","volume":"112","author":"Tonelli","year":"2005","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.iccl.2023.06.006_bib41","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1172\/JCI46122","article-title":"FGF23 induces left ventricular hypertrophy","volume":"121","author":"Faul","year":"2011","journal-title":"J\u00a0Clin Investig"},{"issue":"11","key":"10.1016\/j.iccl.2023.06.006_bib42","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1093\/ndt\/gfy392","article-title":"Fibroblast growth factor-23 promotes rhythm alterations and contractile dysfunction in adult ventricular cardiomyocytes","volume":"34","author":"Navarro-Garc\u00eda","year":"2019","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"10.1016\/j.iccl.2023.06.006_bib43","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.2353\/ajpath.2010.090528","article-title":"Renal Failure Increases Cardiac Histone H3 Acetylation, Dimethylation, and Phosphorylation and the Induction of Cardiomyopathy-Related Genes in Type 2 Diabetes","volume":"176","author":"Gaikwad","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.iccl.2023.06.006_bib44","article-title":"miR-21, Mediator, and Potential Therapeutic Target in the Cardiorenal Syndrome","volume":"11","author":"Huang","year":"2020","journal-title":"Front Pharmacol"},{"issue":"7224","key":"10.1016\/j.iccl.2023.06.006_bib45","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1038\/nature07511","article-title":"MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts","volume":"456","author":"Thum","year":"2008","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.iccl.2023.06.006_bib46","doi-asserted-by":"crossref","first-page":"784","DOI":"10.2741\/4337","article-title":"Chronic kidney disease alters vascular smooth muscle cell phenotype","volume":"20","author":"Monroy","year":"2015","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"4","key":"10.1016\/j.iccl.2023.06.006_bib47","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9040404","article-title":"Vascular Calcification in Chronic Kidney Disease: Diversity in the Vessel Wall","volume":"9","author":"Dube","year":"2021","journal-title":"Biomedicines"},{"issue":"12","key":"10.1016\/j.iccl.2023.06.006_bib48","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1093\/ndt\/gfz133","article-title":"Valvular heart disease and calcification in CKD: more common than appreciated","volume":"35","author":"Ure\u00f1a-Torres","year":"2020","journal-title":"Nephrol Dial Transplant"},{"issue":"12","key":"10.1016\/j.iccl.2023.06.006_bib49","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1038\/ki.2010.334","article-title":"Recent progress in the treatment of vascular calcification","volume":"78","author":"O'Neill","year":"2010","journal-title":"Kidney Int"},{"issue":"20","key":"10.1016\/j.iccl.2023.06.006_bib50","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1056\/NEJM200005183422003","article-title":"Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis","volume":"342","author":"Goodman","year":"2000","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.iccl.2023.06.006_bib51","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1093\/ndt\/15.7.1014","article-title":"Arterial stiffening and vascular calcifications in end-stage renal disease","volume":"15","author":"Gu\u00e9rin","year":"2000","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1016\/j.iccl.2023.06.006_bib52","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/HJH.0b013e32835b15bb","article-title":"Cardiovascular disease in an adenine-induced model of chronic kidney disease: the temporal link between vascular calcification and haemodynamic consequences","volume":"31","author":"Shobeiri","year":"2013","journal-title":"J\u00a0Hypertens"},{"issue":"6","key":"10.1016\/j.iccl.2023.06.006_bib53","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1053\/j.ackd.2019.10.004","article-title":"Valvular Calcification in Chronic Kidney Disease","volume":"26","author":"Brandenburg","year":"2019","journal-title":"Adv Chronic Kidney Dis"},{"issue":"4","key":"10.1016\/j.iccl.2023.06.006_bib54","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1159\/000435838","article-title":"Left Ventricular Hypertrophy in Chronic Kidney Disease Patients: From Pathophysiology to Treatment","volume":"5","author":"Di Lullo","year":"2015","journal-title":"Cardiorenal Med"},{"issue":"1","key":"10.1016\/j.iccl.2023.06.006_bib55","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1001\/jamainternmed.2015.6102","article-title":"Representation of Patients With Kidney Disease in Trials of Cardiovascular Interventions: An Updated Systematic Review","volume":"176","author":"Konstantinidis","year":"2016","journal-title":"JAMA Intern Med"},{"issue":"10041","key":"10.1016\/j.iccl.2023.06.006_bib56","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S0140-6736(16)30508-6","article-title":"The heart and vascular system in dialysis","volume":"388","author":"Wanner","year":"2016","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.iccl.2023.06.006_bib57","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1053\/j.ajkd.2010.11.018","article-title":"Cardiac testing for coronary artery disease in potential kidney transplant recipients: a systematic review of test accuracy studies","volume":"57","author":"Wang","year":"2011","journal-title":"Am J Kidney Dis"},{"issue":"14","key":"10.1016\/j.iccl.2023.06.006_bib58","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/j.jacc.2019.08.1017","article-title":"Chronic Kidney Disease and Coronary Artery Disease: JACC State-of-the-Art Review","volume":"74","author":"Sarnak","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.iccl.2023.06.006_bib59","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.jcmg.2014.12.028","article-title":"Diagnostic Performance of Coronary CT Angiography and Myocardial Perfusion Imaging in Kidney Transplantation Candidates","volume":"8","author":"Winther","year":"2015","journal-title":"JACC Cardiovasc Imaging"},{"issue":"6","key":"10.1016\/j.iccl.2023.06.006_bib60","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1161\/CIRCIMAGING.108.831164","article-title":"Incremental prognostic value of myocardial perfusion imaging in patients referred to stress single-photon emission computed tomography with renal dysfunction","volume":"2","author":"Al-Mallah","year":"2009","journal-title":"Circ Cardiovasc Imaging"},{"issue":"8","key":"10.1016\/j.iccl.2023.06.006_bib61","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.2215\/CJN.00460112","article-title":"Troponin T for the detection of dialysis-induced myocardial stunning in hemodialysis patients","volume":"7","author":"Breidthardt","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.iccl.2023.06.006_bib62","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1590\/2175-8239-jbn-3878","article-title":"Biomarkers of cardio-renal syndrome in uremic myocardiopathy animal model","volume":"40","author":"Dion\u00edsio","year":"2018","journal-title":"J\u00a0Bras Nefrol"},{"issue":"3s","key":"10.1016\/j.iccl.2023.06.006_bib63","article-title":"KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease","volume":"99","year":"2021","journal-title":"Kidney Int"},{"issue":"34","key":"10.1016\/j.iccl.2023.06.006_bib64","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"ESC Guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.iccl.2023.06.006_bib65","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1111\/jch.13861","article-title":"Blood pressure target for hypertension in chronic kidney disease: One size does not fit all","volume":"22","author":"Kollias","year":"2020","journal-title":"J\u00a0Clin Hypertens"},{"issue":"9739","key":"10.1016\/j.iccl.2023.06.006_bib66","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0140-6736(10)60576-4","article-title":"Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial","volume":"376","author":"Ismail-Beigi","year":"2010","journal-title":"Lancet"},{"issue":"9131","key":"10.1016\/j.iccl.2023.06.006_bib67","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group","volume":"352","year":"1998","journal-title":"Lancet"},{"issue":"15","key":"10.1016\/j.iccl.2023.06.006_bib68","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1056\/NEJMoa1407963","article-title":"Follow-up of blood-pressure lowering and glucose control in type 2 diabetes","volume":"371","author":"Zoungas","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.iccl.2023.06.006_bib69","first-page":"Cd008143","article-title":"Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus","author":"Hemmingsen","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.iccl.2023.06.006_bib70","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1016\/j.amjcard.2017.05.012","article-title":"EMPA-REG OUTCOME: The Nephrologist\u2019s Point of View","volume":"120","author":"Wanner","year":"2017","journal-title":"Am J Cardiol"},{"issue":"4","key":"10.1016\/j.iccl.2023.06.006_bib71","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"issue":"19","key":"10.1016\/j.iccl.2023.06.006_bib72","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","article-title":"Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"issue":"10193","key":"10.1016\/j.iccl.2023.06.006_bib73","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0140-6736(19)31149-3","article-title":"Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial","volume":"394","author":"Gerstein","year":"2019","journal-title":"Lancet"},{"issue":"9784","key":"10.1016\/j.iccl.2023.06.006_bib74","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/S0140-6736(11)60739-3","article-title":"The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial","volume":"377","author":"Baigent","year":"2011","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.iccl.2023.06.006_bib75","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJMoa043545","article-title":"Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis","volume":"353","author":"Wanner","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"14","key":"10.1016\/j.iccl.2023.06.006_bib76","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa0810177","article-title":"Rosuvastatin and cardiovascular events in patients undergoing hemodialysis","volume":"360","author":"Fellstr\u00f6m","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"23","key":"10.1016\/j.iccl.2023.06.006_bib77","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1016\/j.jacc.2019.03.513","article-title":"Efficacy and Safety of Evolocumab in Chronic Kidney Disease in the FOURIER Trial","volume":"73","author":"Charytan","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.iccl.2023.06.006_bib78","first-page":"Cd008834","article-title":"Antiplatelet agents for chronic kidney disease","author":"Palmer","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"10073","key":"10.1016\/j.iccl.2023.06.006_bib79","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/S0140-6736(17)30397-5","article-title":"Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials","volume":"389","author":"Costa","year":"2017","journal-title":"Lancet"},{"issue":"16","key":"10.1016\/j.iccl.2023.06.006_bib80","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1001\/jama.2016.3775","article-title":"Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary Intervention","volume":"315","author":"Yeh","year":"2016","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.iccl.2023.06.006_bib81","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1161\/CIRCULATIONAHA.119.040167","article-title":"Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention","volume":"140","author":"Urban","year":"2019","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.iccl.2023.06.006_bib82","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.2215\/CJN.05551008","article-title":"Early angiography in patients with chronic kidney disease: a collaborative systematic review","volume":"4","author":"Charytan","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"17","key":"10.1016\/j.iccl.2023.06.006_bib83","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1056\/NEJMoa1915925","article-title":"Management of Coronary Disease in Patients with Advanced Kidney Disease","volume":"382","author":"Bangalore","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.iccl.2023.06.006_bib84","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s12928-020-00660-8","article-title":"Contrast-induced acute kidney injury","volume":"35","author":"Chandiramani","year":"2020","journal-title":"Cardiovasc Interv Ther"},{"issue":"4","key":"10.1016\/j.iccl.2023.06.006_bib85","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.cardfail.2008.11.003","article-title":"The influence of renal function on clinical outcome and response to beta-blockade in systolic heart failure: insights from Metoprolol CR\/XL Randomized Intervention Trial in Chronic HF (MERIT-HF)","volume":"15","author":"Ghali","year":"2009","journal-title":"J\u00a0Card Fail"},{"issue":"11","key":"10.1016\/j.iccl.2023.06.006_bib86","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.jacc.2011.04.041","article-title":"Effects of beta-adrenergic antagonists in patients with chronic kidney disease: a systematic review and meta-analysis","volume":"58","author":"Badve","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.iccl.2023.06.006_bib87","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.amjmed.2011.10.013","article-title":"Renin-angiotensin inhibition in systolic heart failure and chronic kidney disease","volume":"125","author":"Ahmed","year":"2012","journal-title":"Am J Med"},{"issue":"5","key":"10.1016\/j.iccl.2023.06.006_bib88","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1161\/HYPERTENSIONAHA.116.08952","article-title":"Continuum of Renin-Independent Aldosteronism in Normotension","volume":"69","author":"Baudrand","year":"2017","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.iccl.2023.06.006_bib89","doi-asserted-by":"crossref","first-page":"542","DOI":"10.2215\/CJN.04750908","article-title":"Aldosterone antagonists for preventing the progression of chronic kidney disease: a systematic review and meta-analysis","volume":"4","author":"Navaneethan","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"10","key":"10.1016\/j.iccl.2023.06.006_bib90","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.iccl.2023.06.006_bib91","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1009492","article-title":"Eplerenone in patients with systolic heart failure and mild symptoms","volume":"364","author":"Zannad","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"23","key":"10.1016\/j.iccl.2023.06.006_bib92","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMoa2025845","article-title":"Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes","volume":"383","author":"Bakris","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.iccl.2023.06.006_bib93","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.kint.2018.11.025","article-title":"A\u00a0randomized controlled trial of the effect of spironolactone on left ventricular mass in hemodialysis patients","volume":"95","author":"Hammer","year":"2019","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.iccl.2023.06.006_bib94","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.kint.2018.08.034","article-title":"Safety and cardiovascular efficacy of spironolactone in dialysis-dependent ESRD (SPin-D): a randomized, placebo-controlled, multiple dosage trial","volume":"95","author":"Charytan","year":"2019","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.iccl.2023.06.006_bib95","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1161\/CIRCHEARTFAILURE.107.746933","article-title":"Admission or changes in renal function during hospitalization for worsening heart failure predict postdischarge survival: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF)","volume":"1","author":"Klein","year":"2008","journal-title":"Circ Heart Fail"},{"issue":"12","key":"10.1016\/j.iccl.2023.06.006_bib96","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.cardfail.2010.07.246","article-title":"Impact of dopamine infusion on renal function in hospitalized heart failure patients: results of the Dopamine in Acute Decompensated Heart Failure (DAD-HF) Trial","volume":"16","author":"Giamouzis","year":"2010","journal-title":"J\u00a0Card Fail"},{"issue":"3","key":"10.1016\/j.iccl.2023.06.006_bib97","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jacc.2008.02.083","article-title":"Sodium nitroprusside for advanced low-output heart failure","volume":"52","author":"Mullens","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.iccl.2023.06.006_bib98","doi-asserted-by":"crossref","first-page":"17","DOI":"10.5049\/EBP.2013.11.1.17","article-title":"Pharmacologic Management of the Cardio-renal Syndrome","volume":"11","author":"Kim","year":"2013","journal-title":"Electrolyte Blood Press"},{"issue":"15","key":"10.1016\/j.iccl.2023.06.006_bib99","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa0912613","article-title":"Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure","volume":"363","author":"Massie","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"15","key":"10.1016\/j.iccl.2023.06.006_bib100","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","article-title":"Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure","volume":"383","author":"Packer","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"16","key":"10.1016\/j.iccl.2023.06.006_bib101","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in Heart Failure with a Preserved Ejection Fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.iccl.2023.06.006_bib102","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1001\/jamacardio.2020.4511","article-title":"Association of SGLT2 Inhibitors With Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes: A Meta-analysis","volume":"6","author":"McGuire","year":"2021","journal-title":"JAMA Cardiology"},{"issue":"6","key":"10.1016\/j.iccl.2023.06.006_bib103","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jacc.2006.07.073","article-title":"Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure","volume":"49","author":"Costanzo","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"24","key":"10.1016\/j.iccl.2023.06.006_bib104","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1056\/NEJMoa1210357","article-title":"Ultrafiltration in decompensated heart failure with cardiorenal syndrome","volume":"367","author":"Bart","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.iccl.2023.06.006_bib105","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jchf.2015.08.005","article-title":"Aquapheresis Versus Intravenous Diuretics and Hospitalizations for Heart Failure","volume":"4","author":"Costanzo","year":"2016","journal-title":"JACC Heart Fail"},{"issue":"3","key":"10.1016\/j.iccl.2023.06.006_bib106","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1093\/ndt\/gfz182","article-title":"Sudden cardiac death in dialysis patients: different causes and management strategies","volume":"36","author":"Genovesi","year":"2021","journal-title":"Nephrol Dial Transplant"},{"issue":"12","key":"10.1016\/j.iccl.2023.06.006_bib107","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/ncpneph0345","article-title":"Timing of sudden death relative to the hemodialysis procedure","volume":"2","author":"Perl","year":"2006","journal-title":"Nat Clin Pract Nephrol"},{"issue":"11","key":"10.1016\/j.iccl.2023.06.006_bib108","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1093\/europace\/eup282","article-title":"Implantable cardioverter defibrillator therapy in chronic kidney disease: a meta-analysis","volume":"11","author":"Korantzopoulos","year":"2009","journal-title":"Europace"},{"issue":"10","key":"10.1016\/j.iccl.2023.06.006_bib109","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/j.hrthm.2015.06.033","article-title":"Temporal distribution of arrhythmic events in chronic kidney disease: Highest incidence in the long interdialytic period","volume":"12","author":"Wong","year":"2015","journal-title":"Heart Rhythm"},{"issue":"3","key":"10.1016\/j.iccl.2023.06.006_bib110","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jacep.2017.08.002","article-title":"Cardiac Rhythm Disturbances in Hemodialysis Patients: Early Detection Using an Implantable Loop Recorder and Correlation With Biological and Dialysis Parameters","volume":"4","author":"Sacher","year":"2018","journal-title":"JACC Clin Electrophysiol"},{"issue":"4","key":"10.1016\/j.iccl.2023.06.006_bib111","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2174\/1573403X13666170804151608","article-title":"Impact of Pre-existing Kidney Dysfunction on Outcomes Following Transcatheter Aortic Valve Replacement","volume":"13","author":"Ifedili","year":"2017","journal-title":"Curr Cardiol Rev"},{"issue":"5","key":"10.1016\/j.iccl.2023.06.006_bib112","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1016\/j.jtcvs.2013.12.064","article-title":"Outcomes of cardiac surgery in chronic kidney disease","volume":"148","author":"Fernando","year":"2014","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"issue":"36","key":"10.1016\/j.iccl.2023.06.006_bib113","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1093\/eurheartj\/ehx391","article-title":"ESC\/EACTS Guidelines for the management of valvular heart disease","volume":"38","author":"Baumgartner","year":"2017","journal-title":"Eur Heart J"},{"issue":"18","key":"10.1016\/j.iccl.2023.06.006_bib114","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1056\/NEJMoa1816885","article-title":"Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients","volume":"380","author":"Popma","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"18","key":"10.1016\/j.iccl.2023.06.006_bib115","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1056\/NEJMoa1814052","article-title":"Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients","volume":"380","author":"Mack","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.iccl.2023.06.006_bib116","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.amjcard.2017.12.015","article-title":"Comparison of Transcatheter Mitral Valve Repair Versus Surgical Mitral Valve Repair in Patients With Advanced Kidney Disease (from the National Inpatient Sample)","volume":"121","author":"Doshi","year":"2018","journal-title":"Am J Cardiol"},{"issue":"11_Supplement","key":"10.1016\/j.iccl.2023.06.006_bib117","doi-asserted-by":"crossref","first-page":"A1980","DOI":"10.1016\/S0735-1097(18)32521-X","article-title":"OUTCOMES AFTER TRANSCATHETER MITRAL VALVE REPAIR IN PATIENTS WITH CHRONIC KIDNEY DISEASE: AN ANALYSIS OF 5,241 PATIENTS IN THE UNITED STATES","volume":"71","author":"Shah","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.iccl.2023.06.006_bib118","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1172\/JCI61405","article-title":"FGF23 neutralization improves chronic kidney disease-associated hyperparathyroidism yet increases mortality","volume":"122","author":"Shalhoub","year":"2012","journal-title":"J\u00a0Clin Invest"},{"issue":"9","key":"10.1016\/j.iccl.2023.06.006_bib119","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1093\/ndt\/gfw454","article-title":"Vitamin D treatment attenuates cardiac FGF23\/FGFR4 signaling and hypertrophy in uremic rats","volume":"32","author":"Leifheit-Nestler","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.iccl.2023.06.006_bib120","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.yjmcc.2019.04.025","article-title":"Cardiac arrhythmias after renal I\/R depend on IL-1\u03b2","volume":"131","author":"Alarcon","year":"2019","journal-title":"Journal of Molecular and Cellular Cardiology"},{"issue":"1","key":"10.1016\/j.iccl.2023.06.006_bib121","doi-asserted-by":"crossref","first-page":"13344","DOI":"10.1038\/ncomms13344","article-title":"Macrophage-dependent IL-1\u03b2 production induces cardiac arrhythmias in diabetic mice","volume":"7","author":"Monnerat","year":"2016","journal-title":"Nat Commun"}],"container-title":["Interventional Cardiology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211745823000469?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211745823000469?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T02:43:05Z","timestamp":1716604985000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211745823000469"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":121,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S2211745823000469"],"URL":"https:\/\/doi.org\/10.1016\/j.iccl.2023.06.006","relation":{},"ISSN":["2211-7458"],"issn-type":[{"value":"2211-7458","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Significance of Kidney Disease in Cardiovascular Disease Patients","name":"articletitle","label":"Article Title"},{"value":"Interventional Cardiology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.iccl.2023.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}